<DOC>
	<DOCNO>NCT00622986</DOCNO>
	<brief_summary>This study design determine whether extract Cimicifuga Foetida L. safe efficacious relieve climacteric symptom Chinese woman</brief_summary>
	<brief_title>China Cimicifuga Trial Climacteric Complaint Control</brief_title>
	<detailed_description>Extracts Cimicifuga Racemosa ( black cohosh ) widely use North America Europe decades treatment menopause relate problem , either nutritional supplement pharmaceutical product . Previous clinical trial show extract Cimicifuga Foetida L. ( Ximingting , Luyepharm ) , standardize similar component extract Cimicifuga Racemosa , safe efficacious relieve climacteric symptom sign Chinese woman recruit accord criterion categorize theory Traditional Chinese Medicine.We interest know whether may efficacy safety profile judge method standard commonly accept western medicine .</detailed_description>
	<criteria>Having climacteric symptom hot flush &gt; = 3 time per day Score Kupperman Index baseline &gt; = 20 In addition criterion , woman menopause long 2 month le 12 month , FSH &gt; 15U/L enrolled perimenopausal group . Women menopause longer 12 month le 5 year , FSH &gt; = 40U/L E2 &lt; = 30pg/ml , assign early stag postmenopausal group . Having history hysterectomy Having HRT within 6 week Having drug nutritional supplement relieve climacteric symptom within one week Having psychological counseling within one week Having medical history estrogendependent tumors The result pap smear exam stage III Having uterine leiomyoma lager 4 cm The endometrial thickness lager 0.5 cm Having abnormal cardiac , liver kidney function Having abnormal thyroid function Having hypertension , diabetes coronary heart diseases control Pregnant suspect pregnant woman Having severe mental disorder inhibit understand research purpose Other condition investigator believe suitable enrollment</criteria>
	<gender>Female</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>February 2008</verification_date>
</DOC>